Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 39 for “"Prostatic neoplasms"”.
-
Determinants of prostate cancer: the Birmingham Prostatic Neoplasms Association study
This Birmingham Prostatic Neoplasms Association Study (BiPAS) was initiated to investigate determinants of prostate cancer. The study recruited 314 prostate cancer patients, 381 active surveillance patients, 201 hospital controls and 175 population controls. By comparing groups of varying risk, the …
-
UBE2J1 Is the E2 Ubiquitin Conjugating Enzyme Regulating AR Degradation and Resistance to Antiandrogen
Prostate cancer (PCa) is primarily driven by aberrant Androgen Receptor (AR) signaling. Although there has been substantial advancement in antiandrogen therapies, resistance to these treatments remains a significant obstacle, often marked by continuous or enhanced AR signaling in resistant tumors. …
-
An Exploration of Life Expectancy Calculation Methods to Aid in Prostate Cancer Screening and Treatment Decision-Making
Background: Life expectancy (LE) estimation is an important part of both screening and treatment decision-making for potentially curable prostate cancer. Clinicians’ estimation of patient life expectancy is typically made using population-based life tables and intuition and it is often inaccurate. …
-
Prostate cancer-specific suvival differences between radical prostatectomy and curative radiotherapy
Background: The relative treatment effectiveness of surgery versus radiotherapy for early-stage prostate cancer is uncertain and randomized clinical trials are unlikely to be performed. This study describes the difference in cause-specific survival between patients treated with radiotherapy versus …
-
FHIT expression in prostate tumors
This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).
-
Antioxidant Programs Are Essential for Enzalutamide-Resistant Prostate Cancer
Therapy resistance to second generation androgen receptor (AR) antagonists, such as enzalutamide, is common in patients with advanced prostate cancer (PCa). In order to identify which patients will develop therapy resistance and the underlying cause, it is critical to characterize detailed …
-
Developing Mouse Models to Study Lineage Transcription Factor Functions in Neuroendocrine Prostate Cancer
Most patients with prostate adenocarcinoma develop resistance to therapies targeting the androgen receptor (AR). Consequently, a portion of these patients develop AR-independent neuroendocrine prostate cancer (NEPC), a rapidly progressing cancer with limited therapies and poor survival outcomes. …
-
Targeted Molecular Imaging: A Guide to Combination Therapy
Recombinant adenovirus is widely used to deliver genes for cancer gene therapy. Coxsackie and Adenovirus' Receptor (CAR) is the primary receptor for recombinant adenovirus. Little attention has been paid to determine CAR protein expression and promoter activity in vivo. This study tested the …
-
Prostate-specific Antigen Nadir and Time to Prostate-specific Antigen Nadir Following Maximal Androgen Blockade Independently Predict the Prognosis in Patients with Metastatic Prostate Cancer
PURPOSE: To evaluate the influence of prostate-specific antigen (PSA) kinetics following maximal androgen blockade (MAB) on the disease progression and cancer-specific survival in patients with metastatic, hormone sensitive prostate cancer. MATERIALS AND METHODS: One hundred thirty-one patients …
-
The Role of Exercise on Masculinity, Body Image, and Quality of Life in Men with Prostate Cancer. A Mixed Methods Study.
Early research supports exercise in its role to improve masculinity and body image changes that may result from treatment; however, studies to date have largely examined limited treatment groups (i.e., those receiving androgen deprivation therapy) and did not include men from across the exercise …
-
Die diagnostische Validität des Macrophage Migration Inhibitory Factor (MIF) im Serum von Patienten mit Prostatakarzinom (PCa)
Ziel der Dissertation war es, zu prüfen, ob die Bestimmung des Zytokins Macrophage Migration Inhibitory Factor (MIF) im Serum die Früherkennung des Prostatakarzinoms (PCa) verbessern kann. In einer initialen Studie konnten wir zeigen, dass sich die Serum-MIF-Konzentrationen von Patienten mit …
-
Addressing Label Variability in Deep Learning-Based Segmentation for Radiation Therapy
Accurate segmentation of tumor and surrounding organs-at-risk (OARs) is important for radiotherapy treatment(RT) planning. Manual segmentation by physicians currently used in clinical practice is time consuming and highly depends on the physicians' skill and experience, leading to large inter-and …
-
Calidad de vida en pacientes con cáncer de próstata en tratamiento en un instituto de Lima-Perú
Objetivos: La calidad de vida de pacientes en estadios III y IV de cáncer de próstata disminuye significativamente debido a varios factores como: efectos secundarios al tratamiento, pronóstico de la enfermedad, entre otros. Este estudio busca describir qué áreas de la calidad de vida son más …
-
Funktionelle Bildgebung der Vaskularisation und Perfusion des Prostatakarzinoms mit dynamischer MRT
In den westlichen Industrieländern ist das Prostatakarzinom das häufigste Malignom beim Mann und das am zweithäufigsten zum Tode führende Tumorleiden des Mannes. Die bisher einzige Möglichkeit, ein Prostatakarzinom frühzeitig zu diagnostizieren, ist die histologische Untersuchung von …
-
The Potential Role of LEDGF/p75 in Prostate Cancer
The serum autoantibody repertoire from cancer patients is currently being exploited for the identification of tumor associated antigens (TAA) and the design of TAA arrays. Such arrays would facilitate autoantibody profiling and potentially aid in the serological diagnosis and prognosis of tumors. …
-
Determination of the Optimal Targeted Prostate Biopsy Strategy
BACKGROUND: Prostate cancer is one of the leading causes of cancer-related mortality in men and is treated in different ways based on the aggressiveness of the disease. The traditional method of diagnosis has been the systematic biopsy, which frequently underestimates or completely misses the …
-
Regulation of PIM1 Under Hypoxia in Prostate Cancer
A defining characteristic of solid tumors is the capacity to divide and spread under conditions of nutrient deprivation and limited oxygen availability. These microenvironmental stresses arise from structural abnormalities in tumor vessels that lead to aberrant microcirculation. Hypoxia acts as a …
-
Contribution of the LEDGF/p75 Protein Interactome to Prostate Cancer Chemoresistance
Prostate Cancer (PCa) progression leads to an advanced stage called metastatic castration resistant PCa (mCRPC), for which currently there is no cure in spite of advances in treatment with new generation anti-androgen drugs and chemotherapy with taxanes such as docetaxel (DTX). Our laboratory …
-
Telomerase Activity in Prostatic Fluid and Tissue as a Marker for Prostate Cancer
… needle biopsy specimens and freshly collected prostatic fluid. Clinical application of a newly developed PCR-ELISA telomerase assay method is also evaluated. Multiple sextant needle biopsy specimens from 56 subjects and prostatic secretion specimens from 72 subjects, with or without prostate …
-
How Prostate Cancer Cell Modify Lineage and Microenviroment to Escape Targeted Therapy
Prostate cancer (PCa) is a leading cause of cancer-related deaths among men worldwide. The primary treatment-androgen deprivation therapy (ADT) often faces resistance and leads to metastatic castration-resistant prostate cancer (mCRPC). This thesis explores the emerging mechanisms underlying …
Page 1 of 2